Michael Silverberg to Case-Control Studies
This is a "connection" page, showing publications Michael Silverberg has written about Case-Control Studies.
Connection Strength
0.681
-
Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
Score: 0.144
-
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol. 2018 01; 131(1):47-55.
Score: 0.122
-
Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS. 2016 10; 30(10):463-470.
Score: 0.112
-
The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):321-7.
Score: 0.083
-
HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS. 2011 Sep 10; 25(14):1771-7.
Score: 0.079
-
Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proc Natl Acad Sci U S A. 2018 10 23; 115(43):11018-11023.
Score: 0.032
-
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. HIV Med. 2018 02; 19(2):90-101.
Score: 0.030
-
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017 Jul; 17(7):1823-1832.
Score: 0.029
-
Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all? Antivir Ther. 2016; 21(6):529-534.
Score: 0.027
-
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncol. 2014 Dec; 50(12):1169-76.
Score: 0.024